Literature DB >> 3457692

Prostaglandins and echocardiography in the assessment of patent ductus arteriosus.

C Hammerman, E Strates, S Berger, W Zaia, A Aldousany.   

Abstract

Prostaglandin (PG) levels and M-mode echocardiography were used to evaluate the severity of patent ductus arteriosus (PDA) in 19 premature infants. Mean 6-keto-PGF1 alpha levels in infants with more severe left-to-right shunting were significantly higher than those in infants with a moderate level of shunting (1335 +/- 763 vs. 504 +/- 348 pg/ml, respectively). Furthermore, there was a significant correlation between this elevation and a decrease in the left ventricular systolic time interval, suggesting that both reflect the severity of ductal shunting. Although other echocardiographic measurements of cardiovascular function generally showed some tendency to vary with 6-keto-PGF1 alpha levels, none was as closely correlated with the extent of PG elevation. Levels of PGE2 also seemed to vary with PDA severity; however, this correlation was not as significant.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3457692     DOI: 10.1097/00003246-198605000-00005

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

1.  Endogenous dilator prostaglandins in congenital heart disease.

Authors:  C Hammerman; M J Aramburo; K C Bui
Journal:  Pediatr Cardiol       Date:  1987       Impact factor: 1.655

2.  Prostacyclin concentrations and transitional circulation in preterm infants requiring mechanical ventilation.

Authors:  M Kluckow; N Evans; G Leslie; J Rowe
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-01       Impact factor: 5.747

3.  The silent ductus: its precursors and its aftermath.

Authors:  C Hammerman; E Strates; S Valaitis
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

4.  Prostaglandin levels: predictors of indomethacin responsiveness.

Authors:  C Hammerman; W Zaia; S Berger; E Strates; A Aldousany
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.